DE602004021638D1 - Fluconazol-tinidazol-kombination zur behandlung von vaginalen infektionen, zusammensetzung daraus und ihre anwendung - Google Patents

Fluconazol-tinidazol-kombination zur behandlung von vaginalen infektionen, zusammensetzung daraus und ihre anwendung

Info

Publication number
DE602004021638D1
DE602004021638D1 DE602004021638T DE602004021638T DE602004021638D1 DE 602004021638 D1 DE602004021638 D1 DE 602004021638D1 DE 602004021638 T DE602004021638 T DE 602004021638T DE 602004021638 T DE602004021638 T DE 602004021638T DE 602004021638 D1 DE602004021638 D1 DE 602004021638D1
Authority
DE
Germany
Prior art keywords
tinidazol
fluconazole
treatment
composition
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004021638T
Other languages
English (en)
Inventor
Ramirez Luisa Hernandez
Paniagua Angelica Arzola
Salgado Lopez Raul E Garcia
Lopez Fernando Poot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alparis SA de CV
Original Assignee
Alparis SA de CV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alparis SA de CV filed Critical Alparis SA de CV
Publication of DE602004021638D1 publication Critical patent/DE602004021638D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE602004021638T 2004-01-22 2004-12-17 Fluconazol-tinidazol-kombination zur behandlung von vaginalen infektionen, zusammensetzung daraus und ihre anwendung Expired - Fee Related DE602004021638D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/762,616 US8309103B2 (en) 2004-01-22 2004-01-22 Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
PCT/MX2004/000094 WO2005070421A1 (es) 2004-01-22 2004-12-17 Asociación de fluconazol-tinidazol para el tratamiento de infecciones vaginales, su composición, proceso de preparación y uso

Publications (1)

Publication Number Publication Date
DE602004021638D1 true DE602004021638D1 (de) 2009-07-30

Family

ID=34794897

Family Applications (2)

Application Number Title Priority Date Filing Date
DE04808700T Pending DE04808700T1 (de) 2004-01-22 2004-12-17 Fluconazol-tinidazol-kombination zur behandlung von vaginalen infektionen, zusammensetzung daraus und ihre anwendung
DE602004021638T Expired - Fee Related DE602004021638D1 (de) 2004-01-22 2004-12-17 Fluconazol-tinidazol-kombination zur behandlung von vaginalen infektionen, zusammensetzung daraus und ihre anwendung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE04808700T Pending DE04808700T1 (de) 2004-01-22 2004-12-17 Fluconazol-tinidazol-kombination zur behandlung von vaginalen infektionen, zusammensetzung daraus und ihre anwendung

Country Status (8)

Country Link
US (1) US8309103B2 (de)
EP (1) EP1712229B1 (de)
JP (1) JP2007518797A (de)
BR (1) BRPI0418065A (de)
CA (1) CA2553646C (de)
DE (2) DE04808700T1 (de)
ES (1) ES2280150T3 (de)
WO (1) WO2005070421A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008011321A (es) 2008-09-04 2010-03-04 Senosiain S A De C V Lab Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual.
CA2959414C (en) 2014-09-05 2023-03-14 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis
CA2988082C (en) 2015-06-01 2020-09-29 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2581707B2 (ja) 1987-10-02 1997-02-12 科研製薬株式会社 抗真菌剤組成物
US5536743A (en) 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
KR100190254B1 (ko) * 1991-01-30 1999-06-01 레슬리 에드워즈 수-분산성 정제
GB9610359D0 (en) * 1996-05-17 1996-07-24 Edko Trading Representation Pharmaceutical compositions
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
US6416779B1 (en) 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
EP1072269B1 (de) 1997-11-24 2005-10-12 Zhongming Zeng Verwendung von dextrin, stärke oder glykogen zur behandlung von bakterieller vaginosis
US20030059471A1 (en) * 1997-12-15 2003-03-27 Compton Bruce Jon Oral delivery formulation
FR2777783A1 (fr) * 1998-04-24 1999-10-29 Innothera Lab Sa Association pharmaceutique d'imidazoles pour le traitement local des vulvo-vaginites infectieuses et des vaginoses
EP2374889A3 (de) 1998-12-08 2012-02-22 GlaxoSmithKline Biologicals SA Neue Verbindungen
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
AU2001264110A1 (en) * 2000-06-15 2001-12-24 Ssl International Plc Parasiticidal composition
US20030017207A1 (en) 2001-05-01 2003-01-23 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
US20030064103A1 (en) 2001-05-01 2003-04-03 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
US20030130225A1 (en) * 2001-10-16 2003-07-10 Nawaz Ahmad Novel methods of treating local fungal and bacterial infections
MXPA02007641A (es) 2002-08-08 2004-04-02 Alparis Sa De Cv Uso de farmaceutico de la combinacion de fluconazol-tinidazol y su composicion para la administracion oral.
US20040033968A1 (en) * 2002-08-16 2004-02-19 Lin Shun Y. Optimal volume of intra-vaginal semisolid dosage forms for treating vaginal infections

Also Published As

Publication number Publication date
EP1712229B1 (de) 2009-06-17
ES2280150T1 (es) 2007-09-16
CA2553646C (en) 2012-01-31
US8309103B2 (en) 2012-11-13
ES2280150T3 (es) 2009-11-18
EP1712229A1 (de) 2006-10-18
DE04808700T1 (de) 2007-08-09
BRPI0418065A (pt) 2007-04-17
US20050165077A1 (en) 2005-07-28
JP2007518797A (ja) 2007-07-12
WO2005070421A1 (es) 2005-08-04
CA2553646A1 (en) 2005-08-04

Similar Documents

Publication Publication Date Title
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
ATE448206T1 (de) Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen
DE502005007427D1 (de) 3-aminoindazole derivate und ihre verwendung zur behandlung sgk-bedingten krankheiten
ATE369333T1 (de) Sulfonamidderivate zur behandlung von krankheiten
ATE519488T1 (de) Aminopyrazin-analoga zur behandlung von glaukomen und anderen durch rho-kinase verursachten krankheiten
ATE375977T1 (de) Sulfonamidderivate zur behandlung von krankheiten
ATE512663T1 (de) Kombination zur behandlung von erkrankungen mit zellproliferation
DE602004028763D1 (de) Te zur behandlung von virenerkrankungen
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
DE602004023342D1 (de) Siliconzusammensetzung und diese enthaltendes Papierbehandlungsmittel
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
DE502005003904D1 (de) Tetrahydrobenzo (d) azepin-2-on derivate und ihre verwendung zur behandlung von kardiovaskulären krankheiten
DE602004010708D1 (de) Imidazopyridinsubstituierte tropanderivate mit ccr5-rezeptorantagonistischer wirkung zur behandlung von hiv und entzündungen
ATE446754T1 (de) Verbindungen zur behandlung von schizophrenie und/oder glucoregulatorische auffälligkeiten
IL178094A0 (en) Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
DE602006009786D1 (de) Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
ATE472324T1 (de) Isosorbid-mononitrat-derivate zur behandlung von okularer hypertonie
NO20070892L (no) Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse.
ATE479716T1 (de) Copolymerisate und ihre verwendung zur behandlung von flexiblen substraten
BRPI0614481A2 (pt) composto, composição farmecêutica, uso do composto, e, método de tratamento de distúrbios mediados por mglur5
ATE474840T1 (de) 6-heteroarylpyridoindolon-derivate, ihre herstellung und ihre therapeutische anwendung
DE50114605D1 (de) No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee